Federal Register / Vol. 63, No. 88 /Thursday, May 7, 1998 / Notices 25221

Time: 9:30 a.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. Dan McDonald,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4214, Bethesda,

Maryland 20892, (301) 435–1215

Name of SEP: Microbiological and

Immunological Sciences.

Date: May 13, 1998.

Time: 10:00 a.m.

Place: NIH, Rockledge 2, Room 4182,

Telephone Conference.

Contact Person: Dr. William Branche,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4182, Bethesda,

Maryland 20892, (301) 435–1148.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the grant review and funding

cycle.

Name of SEP: Behavioral and

Neurosciences.

Date: May 21, 1998.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 5172,

Telephone Conference.

Contact Person: Dr. Leonard Jakubczak,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5172, Bethesda,

Maryland 20892, (301) 435–1247.

Name of SEP: Behavioral and

Neurosciences.

Date: June 16–18, 1998.

Time: 8:30 a.m.

Place: Doubletree Hotel, Rockville, MD.

Contact Person: Dr. Syed Husain, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5216, Bethesda, Maryland 20892, (301)

435–1224.

Name of SEP: Behavioral and

Neurosciences.

Date: June 23–25, 1998.

Time: 8:30 a.m.

Place: Radisson Barcelo, Washington, DC.

Contact Person: Dr. Gabrielle LeBlanc,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5218, Bethesda,

Maryland 20892, (301) 435–1218.

Name of SEP: Multidisciplinary Sciences.

Date: June 25, 1998.

Time: 12:00 p.m.

Place: Holiday Inn-Georgetown,

Washington, DC.

Contact Person: Dr. Lee Rosen, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5116, Bethesda, Maryland 20892, (301)

435–1171.

The meetings will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasions of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93,893, National Institutes of Health,

HHS)

Dated: April 29, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–12099 Filed 5–6–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Center

for Scientific Review Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Behavioral and

Neurosciences.

Date: May 12, 1998.

Time: 3:00 p.m.

Place: NIH, Rockledge 2, Room 5172,

Telephone Conference.

Contact Person: Dr. Leonard Jakubczak,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5172, Bethesda,

Maryland 20892, (301) 435–1247.

Name of SEP: Behavioral and

Neurosciences.

Date: May 18, 1998.

Time: 11:00 a.m.

Place: NIH, Rockledge 2, Room 5172,

Telephone Conference.

Contact Person: Dr. Leonard Jakubczak,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5172, Bethesda,

Maryland 20892, (301) 435–1247.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the grant review and funding

cycle.

Name of SEP: Chemistry and Related

Sciences.

Date: June 23–24, 1998..

Time: 8:00 a.m..

Place: Hyatt Regency Hotel, Bethesda, MD.

Contact Person: Dr. Marjam Behar,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5218, Bethesda,

Maryland 20892, (301) 435–1180.

The meetings will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: May 1, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–12101 Filed 5–6–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meeting:

Name of SEP: MR Guided Therapy.

Date: May 26–28, 1998.

Time: May 26—7:00 p.m. to Recess, May

27—8:00 a.m. to Recess, May 28–8:00 a.m. to

Adjournment.

Place: The Inn at Longwood Medical, 342

Longwood Avenue, Boston, MA 02115.

Contact Person: Ray Bramhall, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 643B, 6130 Executive Boulevard, MSC

7405, Bethesda, MD 20892–7405, Telephone:

301/496–3428.

Purpose/Agenda: To review, discuss and

evaluate grant applications.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: April 30, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–12107 Filed 5–6–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as
25222 Federal Register / Vol. 63, No. 88 /Thursday, May 7, 1998 / Notices

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Center for Research Resources

Special Emphasis Panel (SEP) meeting:

Name of SEP: Research Centers in Minority

Institutions.

Date: June 1, 1998.

Time: 5:00 p.m.

Place: Doubletree Hotel, 1750 Rockville

Pike, Rockville, MD 20852, (301) 468–1100.

Contact Person: Dr. Bela J. Gulyas,

Scientific Review Administrator, 6705

Rockledge Drive, MSC 7965, Room 6018,

Bethesda, MD 20892–7965, (301) 435–0811.

Purpose/Agenda: To evaluate and review

grant applications.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.398, Research Centers in

Minority Institutions, National Institutes of

Health, HHS)

Dated: April 29, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–12100 Filed 5–6–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Meetings

Pursuant to Public Law 92–463,

notice is hereby given of the meetings of

the National Center for Research

Resources Initial Review Group and the

Scientific and Technical Review Board

on Biomedical and Behavioral Research

Facilities, National Center for Research

Resources (NCRR), for May and June

1998. These meetings will be open to

the public as indicated below to discuss

program planning; program

accomplishments; administrative

matters such as previous meeting

minutes; the report of the Director,

NCRR; review of budget and legislative

updates; and special reports or other

issues relating to committee business.

Attendance by the public will be limited

to space available.

These meetings will be closed to the

public as indicated below in accordance

with provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and section 10(d) of Public Law 92–463,

for the review, discussion and

evaluation of individual grant

applications. These applications and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Ms. Cheryl A. Fee, Committee

Management Officer, NCRR, National

Institutes of Health, One Rockledge

Centre, Room 5170, 6705 Rockledge

Drive, MSC 7965, Bethesda, Maryland

20892–7965, 301–435–1827, will

provide summaries of meetings and

rosters of committee members. Other

information pertaining to the meetings

can be obtained from the Scientific

Review Administrator indicated.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact the Scientific Review

Administrator listed below, in advance

of the meetings.

Name of Committee: Scientific and

Technical Review Board on Biomedical and

Behavioral Research Facilities.

Date of Meeting: May 27–29, 1998.

Place of Meeting: The Bethesda Ramada,

Embassy Three, 8400 Wisconsin Avenue,

Bethesda, MD 20814, 301–654–1000.

Open: May 27, 8:00 a.m.—9:30 a.m.

Closed: May 27, 9:30—Until Adjournment.

Scientific Review Administrator: Dr. D.G.

Patel, National Institutes of Health, One

Rockledge Centre, Room 6018, 6705

Rockledge Drive, MSC 7965, Bethesda, MD

20892–7965, Telephone: 301–435–0824.

Name of Committee: National Center for

Research Resources Initial Review Group—

Comparative Medicine Review Committee.

Date of Meeting: June 1–2, 1998.

Place of Meeting: Holiday Inn Georgetown,

Kaleidoscope Room, 2101 Wisconsin

Avenue, NW, Washington, DC 20007, 202–

338–4600.

Open: June 1, 8:00 a.m.—9:30 a.m.

Closed: June 2, 9:30—Until Adjournment.

Scientific Review Administrator: Dr.

Raymond O’Neill, National Institutes of

Health, One Rockledge Centre, Room 6018,

6705 Rockledge Drive, MSC 7965, Bethesda,

MD 20892–7965, Telephone: 301–435–0820.

Name of Committee: National Center for

Research Resources Initial Review Group—

Research Centers in Minority Institutions

Review Committee.

Date of Meeting: June 1–3, 1998.

Place of Meeting: Doubletree Hotel,

Twinbrook Room, 1750 Rockville Pike,

Rockville, MD 20852, 301–468–1100

Open: June 1, 8:30 a.m.–10:30 a.m.

Closed: June 1, 10:30 a.m.–Until

Adjournment.

Scientific Review Administrator: Dr. John

Meyers, National Institutes of Health, One

Rockledge Centre, Room 6018, 6705

Rockledge Drive, MSC 7965, Bethesda, MD

20892–7965, Telephone: 301–435–0820.

Name of Committee: National Center for

Research Resources Initial Review Group—

General Clinical Research Centers Review

Committee.

Date of Meeting: June 17–18, 1998.

Place of Meeting: Ramada Inn, Rockville,

1775 Rockville Pike, Montrose Room,

Rockville, MD 20852, 301–881–2300.

Open: June 17, 8:00 a.m.–9:45 a.m.

Closed: June 18, 9:45 a.m.–Until

Adjournment.

Scientific Review Administrator: Dr.

Charles Hollingsworth, National Institutes of

Health, One Rockledge Centre, Room 6018,

6705 Rockledge Drive, MSC 7965, Bethesda,

MD 20892–7965, Telephone: 301–435–0818.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, Laboratory Animal

Sciences and Primate Research; 93.333,

Clinical Research; 93.389, Research Centers

in Minority Institutions; 93.167, Research

Facilities Improvement Program; 93.214

Extramural Research Facilities Construction

Projects, National Institutes of Health)

Dated: April 29, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–12103 Filed 5–6–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Child Health and

Human Development Special Emphasis

Panel (SEP) meeting:

Name of SEP: Data Coordination Center for

the NIH–DC Initiative to Reduce Infant

Mortality in Minority Populations.

Date: May 13, 1998.

Time: 2:00 p.m.–adjournment.

Place: 6100 Executive Boulevard, 6100

Executive Building, Room 5E01, Rockville,

MD, 20852.

Contact Person: Hemeed Khan, Ph.D.,

Scientific Review Administrator, NICHD,

6100 Executive Boulevard, Room 5E01,

Rockville, MD 20852, Telephone: 301–496–

1485.

Purpose/Agenda: To evaluate and review

research grant applications.

This meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The

discussion of these applications could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with these applications, the

disclosure of which would constitute a

clearly unwarranted invasion of personal

privacy.